However, to our present knowledge, no studies have examined the binding of BMS-202 with PD-L1 in GBM cells, and it is still unclear whether it has effects on remodeling the cell metabolism, particularly BCAAs, to prevent their growth. This evidence concerns the gene CD274 and glioblastoma.